StockTipsArenaBeta

BUY Gland Pharma Limited — IDBI Capital

BUYGland Pharma Limited

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))31 Aug 2026via IDBI Capital Research Calls Telegram

Entry₹2,905Stated
Target₹3,070
Total upside +5.68% (call closed)
Stop loss₹2,831-2.55% risk
Exit₹2,8312 Sept 2026, 9:25 am
Stop-loss hit-2.55%
Follow IDBI Capital for new calls(28% target hit, 191 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 199 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
4 supporting0 opposing
Supports the BUY call (4)

Gland Pharma Signs CDMO Deal Targeting USD 90-100 Million Annual Revenue

NewsGoogle News·26 Aug · 1w ago

(opens in new tab)

Gland Pharma FY26 Results: Net profit surges 47% to ₹10,273 mn

NewsGoogle News·25 Aug · 1w ago

(opens in new tab)

The biggest upgrades and downgrades by Jefferies during the Q1 results season

NewsCnbc-Tv18·20 Aug · 2w ago

(opens in new tab)

4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·19 Aug · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.